Glycated Albumin Monitoring

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Washington University School of Medicine
Study ID
NCT07777900
Status
Enrolling By Invitation

Conditions

  • Diabetes

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to learn if the short-term glucose marker (glycated albumin) works as well or better than CGM and/or hemoglobin A1c to indicate to providers that a change in medication is working to improve patient's blood sugar control. Participants will have a blood draw at baseline (when their provider is making a change in medication to treat their diabetes) and also every 4 weeks until the next provider visit. At the end of the study, researchers will compare the time (days, weeks) to see a change in blood glucose control with each of the markers. Participants will be enrolled for up to one year.

Key Dates

First listed
Aug 20, 2026
Start date
Jul 7, 2025
Status verified
Aug 2026
Primary completion
Jan 15, 2027
Completion
Dec 30, 2027

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Has patient's glucose control improved when assessed by glycated albumin measurement? [ Time Frame: every 4 weeks (or as often as available) up to 1 year ]

Locations (1)

FacilityCityStateZIPSite coordinators
Washington University - Core Laboratory for Clinical StudiesSt LouisMissouri63108-

Find similar trials in St Louis, MO

By research site
Washington University - Core Laboratory for Clinical Studies· St Louis, MO

Related Studies